They observed that, regardless of the interaction with membrane environment, EGCG prevented htt fibril formation if lipid vesicles were present, inhibiting amyloid formation [51]; this shows that EGCG is a potential drug candidate for HD treatment and of other conditions involving altered protein aggregation linked to amyloid deposition. The gene discussed is HTT; the disease is Huntington disease.